Management of Diabetic Foot

Publication Date: February 1, 2016
Last Updated: March 21, 2022

Prevention

Prevention of Diabetic Foot Ulceration

We recommend that patients with diabetes undergo annual interval foot inspections by physicians (MD, DO, DPM) or advanced practice providers with training in foot care. ( S , C )
681
We recommend that foot examination include testing for peripheral neuropathy using the Semmes-Weinstein test. ( S , B )
681
We recommend education of the patients and their families about preventive foot care. ( S , C )
681

Therapeutic Footwear:

We suggest against the routine use of specialized therapeutic footwear in average-risk diabetic patients. ( W , C )
681
We recommend using custom therapeutic footwear in high-risk diabetic patients, including those with significant neuropathy, foot deformities, or previous amputation. ( S , B )
681
We suggest adequate glycemic control (hemoglobin A1c <7% with strategies to minimize hypoglycemia) to reduce the incidence of diabetic foot ulcers (DFUs) and infections, with subsequent risk of amputation. ( W , B )
681
We recommend against prophylactic arterial revascularization to prevent DFU. ( S , C )
681

Assessment

Diagnosis of Diabetic Foot Osteomyelitis (DFO)

In patients with a diabetic foot infection (DFI) with an open wound, we suggest doing a probe to bone (PTB) test to aid in diagnosis. ( W , C )
681
In all patients presenting with a new DFI, we suggest that serial plain radiographs of the affected foot be obtained to identify bone abnormalities (deformity, destruction) as well as soft tissue gas and radiopaque foreign bodies. ( W , C )
681
For those patients who require additional (ie, more sensitive or specific) imaging, particularly when soft tissue abscess is suspected or the diagnosis of osteomyelitis remains uncertain, we recommend using magnetic resonance imaging (MRI) as the study of choice. ( S , B )
MRI is a valuable tool for diagnosis of osteomyelitis if the PTB test is inconclusive or if the plain film is not useful.
681
In patients with suspected DFO for whom MRI is contraindicated or unavailable, we suggest a leukocyte or antigranulocyte scan, preferably combined with a bone scan as the best alternative. ( W , B )
681
In patients at high risk for DFO, we recommend that the diagnosis is most definitively established by the combined findings on bone culture and histology. ( S , C )
681
When bone is débrided to treat osteomyelitis, we recommend sending a sample for culture and histology. ( S , C )
681
For patients not undergoing bone débridement, we suggest that clinicians consider obtaining a diagnostic bone biopsy when faced with diagnostic uncertainty, inadequate culture information, or failure of response to empirical treatment. ( W , C )
681

Overview

Title

Management of Diabetic Foot

Authoring Organizations

American Podiatric Medical Association

Society for Vascular Surgery